Pro Dex (PDEX) Other Non-Current Liabilities (2020 - 2022)

Pro Dex (PDEX) posted Other Non-Current Liabilities of $1.2 million for Q1 2022, up 17.46% sequentially from $991000.0 in Q4 2021.

Pro Dex (PDEX) Other Non-Current Liabilities (2020 - 2022) Analysis & Trends

Pro Dex has reported Other Non-Current Liabilities for 3 years, with the latest figure at $1.2 million in Q1 2022.

Quarterly Other Non-Current Liabilities changed N/A year-over-year to $1.2 million in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $1.2 million (changed N/A YoY) and the FY2021 annual result came in at $397000.0, down 50.62% from the prior year.
Other Non-Current Liabilities improved to $1.2 million in Q1 2022 per PDEX's latest filing, from $991000.0 in the prior quarter.
Over five years, Other Non-Current Liabilities peaked at $1.2 million in Q1 2022 and troughed at $397000.0 in Q2 2021.
A 3-year average of $813000.0 and a median of $804000.0 in 2020 frame the typical range for Other Non-Current Liabilities.
The widest YoY moves for Other Non-Current Liabilities: up 50.62% in 2021, down 50.62% in 2021.
Over 3 years, Other Non-Current Liabilities stood at $804000.0 in 2020, then grew by 23.26% to $991000.0 in 2021, then gained by 17.46% to $1.2 million in 2022.
According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $1.2 million, $991000.0, and $709000.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	134.27 Bn	129.05 Bn	1.96 Bn
2	Becton Dickinson	52.56 Bn	51.70 Bn	2.32 Bn
3	Alcon	35.70 Bn	34.35 Bn	1.68 Bn
4	Resmed	33.66 Bn	32.19 Bn	861.22 Mn
5	Medline	29.13 Bn	26.45 Bn	2.22 Bn
6	West Pharmaceutical Services	25.00 Bn	24.56 Bn	329.20 Mn
7	Solventum	15.40 Bn	14.99 Bn	1.29 Bn
8	Cooper Companies	14.79 Bn	14.65 Bn	735.40 Mn
9	Baxter International	13.56 Bn	11.41 Bn	1.03 Bn
10	Pro Dex	211.55 Mn	200.57 Mn	6.13 Mn

Download Data